FDA 483 - Q Urological - March 16, 2020

An FDA inspection of Q Urological in Medfield, MA, a medical device manufacturer, revealed significant deficiencies across its quality system. The firm failed to adequately establish procedures for corrective and preventive actions, complaint handling, management review, and quality audits. These findings indicate a systemic lack of control over critical quality processes.